Advocacy Archives – Page 9 of 11 – Treatment Action Group

Cover image of publication, An Activist's Guide to TB Diagnostic Tools

An Activist’s Guide to Tuberculosis Diagnostic Tools

July 28, 2020
Dorrit Walsh

Our publication, An Activist’s Guide to Tuberculosis Diagnostic Tools, details the latest WHO recommendations, the array of available TB diagnostic tools, and how these tools should be optimally used in country programs, including to support TB screening and diagnosis among special populations such as children, people with extrapulmonary TB, and people living with HIV/AIDS (PLWHA).

Ensuring Universal Access to COVID-19 Diagnosis, Treatment and Prevention

July 27, 2020
Dorrit Walsh

TAG and the Center for Economic and Social Rights produced this joint publication, as part of CESR’s COVID-19 “Recovering Rights” series of briefs.

Civil Rights Groups, Health Advocates, and Public Defenders Celebrate Passage of Legislation to Protect Contact Tracing Data from Law Enforcement

July 23, 2020
Dorrit Walsh

TAG is one of the organizations who supports confidentiality in contact tracing and is applauding the passage of this legislation. As TAG's State and Local Policy Director Annette Gaudino says in this statement, “There can be no effective contact tracing without trust.”

In Memoriam – The Honorable John Lewis

July 21, 2020
Dorrit Walsh

Treatment Action Group (TAG) honors the titanic historic legacy and mourns the recent death of the Honorable John Lewis, U.S. Representative from the 5th Congressional district in Georgia and legendary civil rights leader.

Global Health and Human Rights Organizations Say U.S. Withdrawal from WHO Is Reckless Act That Could Delay Americans’ Access to COVID-19 Solutions and Prolong Global Pandemic

July 7, 2020
Dorrit Walsh

AVAC, Health GAP and the Treatment Action Group (TAG) strongly condemn the Trump Administration’s withdrawal from the World Health Organization (WHO).

Treatment Action Group Statement on Bedaquiline Unaffordability

July 6, 2020
Dorrit Walsh

Treatment Action Group welcomes the Global Drug Facility / Stop TB Partnership's negotiation of what amounts to a 32% savings on bedaquiline, the backbone of improved, all-oral regimens for treating drug-resistant TB.

Treatment Action Group Mourns and Resists Violence towards Black Communities; Demands Action and Accountability across Government and Systems

June 5, 2020
Dorrit Walsh

Treatment Action Group (TAG) joins partners, activists, and communities around the U.S. and the world in decrying violence against Black people and those who stand in solidarity with them.

Treatment Action Group and the PrEP4All Collaboration Respond to Reported Remdesivir Results for COVID-19

April 30, 2020
Dorrit Walsh

Treatment Action Group (TAG) and the PrEP4All Collaboration welcome results from randomized controlled trials of therapies for COVID-19, but are seriously concerned about claims that data from a National Institutes of Allergy and Infectious Diseases (NIAID) study of the Gilead drug remdesivir...

Global Health and Human Rights Organizations Denounce Trump Administration Decision to Pull Commitments to WHO during COVID-19 Crisis

April 16, 2020
Dorrit Walsh

AVAC, Health GAP, Knowledge Ecology International (KEI), and Treatment Action Group (TAG) strongly condemn the Trump Administration’s decision to halt funding to the World Health Organization (WHO) in the midst of the urgent COVID-19 global health crisis.

Treatment Action Group Celebrates New Guidance on the Right to Science by Global Human Rights Body

April 14, 2020
Dorrit Walsh

Treatment Action Group (TAG) celebrates publication of the General Comment on “the human right of everyone to participate in and to enjoy the benefits of scientific progress and its applications” (the right to science), and calls the attention of grassroots activists and global civil society working on health to this landmark document.